(In the weekly Health Matters newsletter, Ramya Kannan writes about getting to good health, and staying there . You can ...
THESE MEDICATIONS ARE MOSTLY KNOWN FOR TREATING DIABETES AND OBESITY.. BUT THE F-D-A HAS APPROVED THEM FOR PREVENTING HEART ...
Cardiovascular diseases such as stroke are a major cause of morbidity and mortality for patients with chronic kidney disease (CKD ... chronic and recurrent infections, dialysis access, changes in ...
This continuous cleansing process helps maintain optimal blood composition and prevents the accumulation of harmful substances that could damage kidney tissue. The process becomes particularly ...
Although obese individuals are at greater risk of diabetes, high blood pressure or high cholesterol, not all obese people ...
Ozempic becomes the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease Mario Tama/Getty The Food and Drug Administration has approved Ozempic to reduce the ...
A new study led by Stony Brook Medicine demonstrates that advanced kidney disease compromises the survival of B cells, a type of infection-fighting white blood cell that produces antibodies to ...
A Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced the risk of kidney disease worsening by 24% in people who also had diabetes. It also reduced the ...
(HealthDay News) — Time-restricted eating (TRE) may not add additional benefit in visceral adipose tissue reduction over the Mediterranean diet for people with overweight or obesity, according to a ...
In its early stages, kidney disease may not cause any symptoms or signs. However, as it progresses, it can cause symptoms such as itchy skin, pruritus, and a rash. Around 35.5 million adults in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results